Target intelligence / Profile preview

Streptococcus pneumoniae type 33F capsular polysaccharide (CPS 33F)

Target
CPS 33F
Molecular classification
Polysaccharide, Capsular Polysaccharide, Antigen
01

Overview

The Streptococcus pneumoniae type 33F capsular polysaccharide is a serotype-specific, high-molecular-weight carbohydrate polymer that forms the outermost layer (capsule) of the bacterium S. pneumoniae serotype 33F. This capsule is a critical virulence factor, enabling the bacterium to evade host immune responses. It is an important target for vaccine development and epidemiological surveillance. Immunization with purified or conjugated form induces production of anti-capsule antibodies that promote opsonophagocytosis and bacterial clearance. Serotype replacement following widespread vaccine use has led to increased prevalence of non-vaccine types like type 33F. Surveillance for emerging variants is essential for ongoing public health efforts.

Other names
S. pneumoniae type 33F capsular polysaccharidePneumococcal polysaccharide type 33FSerotype 33F capsular polysaccharideType 33F CPS
02

Mechanism of action

Induces production of anti-capsular antibodies that promote opsonophagocytosis and bacterial clearance.

03

Biological functions

Immune evasionVirulence factorAntigen presentationOpsonization target
04

Disease associations

PneumoniaMeningitisBacteremiaOtitis mediaSinusitisInfection
05

Safety considerations

Serotype replacementLimited cross-protectionEmergence of new variants (e.g., type 33E)
06

Interacting drugs

Pneumovax 23

1 more in the full profile.

07

Biomarkers

Anti-capsular antibody titersSerotype 33F identification

Beyond the preview

Go deeper on Streptococcus pneumoniae type 33F capsular polysaccharide (CPS 33F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae type 33F capsular polysaccharide (CPS 33F).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call